Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia..     ///    "Minimal residual disease screening over 3 years with nested PCR failed to detect CEP85L-PDGFRB mRNA or genomic DNA, confirming a long-term molecular remission on imatinib.. "    ///    "Here, we report a recurrent CEP85L-PDGFRB fusion in a patient with eosinophilia and an MPN. "